| Literature DB >> 32751090 |
Asmaa B Sabti1, Adil A Al-Fregi2, Majeed Y Yousif2.
Abstract
A novel series of organic tellurium compounds based onEntities:
Keywords: antimicrobial activities; organotellurium; pyrazoles; tellurium tetrabromide; transmetalltion reaction
Mesh:
Substances:
Year: 2020 PMID: 32751090 PMCID: PMC7435781 DOI: 10.3390/molecules25153439
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Preparative methods of compounds 1–3.
Scheme 2Preparative methods of compounds 4–15.
Scheme 3Preparative methods of compounds 16–21.
Scheme 4Preparative methods of compounds 22–27.
Figure 1General structure formula.
13C NMR chemical shifts for compounds 1–15 in DMSO-d6.
| Compound | Pyrazol Ring | Aryl Rings | Substituted Groups | ||||
|---|---|---|---|---|---|---|---|
| C3 | C4 | C5 | Te-C | Ar-H | CH3 | OCH3 | |
|
| 139.80 | 104.66 | 149.62 | 114.90 | 138.80–124.20 | ||
|
| 139.72 | 104.64 | 149.60 | 114.42 | 132.50–124.00 | 21.60 | |
|
| 139.74 | 104.64 | 149.61 | 114.46 | 163.20–121.15 | 56.00 | |
|
| 139.89 | 104.66 | 149.60 | 114.44 | 138.89–124.28 | ||
|
| 139.70 | 104.40 | 149.80 | 114.00 | 132.41–124.24 | 21.73 | |
|
| 139.77 | 104.43 | 149.82 | 114.06 | 163.41–124.70 | 56.60 | |
|
| 139.60 | 104.66 | 149.66 | 114.88 | 138.91–124.33 | ||
|
| 139.50 | 104.34 | 149.60 | 114.00 | 132.38–124.20 | 21.80 | |
|
| 139.52 | 104.34 | 149.62 | 114.06 | 163.41–124.74 | 55.58 | |
|
| 139.56 | 103.71 | 149.66 | 114.14 | 139.56–124.60 | ||
|
| 139.50 | 103.56 | 149.64 | 114.40 | 133.42–124.77 | 21.59 | |
|
| 139.50 | 103.60 | 149.64 | 114.31 | 163.00–124.00 | 55.60 | |
|
| 139.88 | 103.52 | 149.70 | 114.72 | 138.00–124.10 | ||
|
| 139.84 | 103.18 | 149.65 | 114.60 | 132.41–124.78 | 21.60 | |
|
| 139.86 | 103.43 | 149.65 | 114.65 | 163.43–124.77 | 55.59 | |
|
| 139.88 | 103.24 | 149.78 | 114.70 | 138.00–124.74 | ||
|
| 139.70 | 103.20 | 149.71 | 114.65 | 132.40–124.00 | 21.50 | |
|
| 139.52 | 103.20 | 149.63 | 114.66 | 163.45–124.50 | 55.51 | |
|
| 139.80 | 103.60 | 149.75 | 114.79 | 138..43–124.06 | ||
|
| 139.84 | 103.56 | 149.62 | 114.86 | 132.38–125.54 | 21.74 | |
|
| 139.77 | 103.45 | 149.64 | 114.75 | 163.03–124.12 | 55.59 | |
|
| 139.84 | 104.50 | 149.75 | 114.91 | 138.09–124.00 | ||
|
| 139.80 | 103.35 | 149.60 | 114.64 | 133.00–125.22 | 21.82 | |
|
| 139.63 | 104.34 | 149.66 | 114.80 | 163.00–124.66 | 55.60 | |
|
| 139.85 | 103.95 | 149.79 | 114.83 | 138.05–124.91 | ||
|
| 139.76 | 103.88 | 149.61 | 114.70 | 132.11–124.00 | 21.77 | |
|
| 139.65 | 103.89 | 149.60 | 114.76 | 163.40–124.99 | 55.60 | |
Inhibition zones (mm) of synthetic compounds 1–27.
| COMP. | Diameter of Inhibition Zone (mm) | |||
|---|---|---|---|---|
| Gram Positive Bacteria | Gram Negative Bacteria | |||
|
|
|
|
| |
|
| 18 | 16 | 19 | 13 |
|
| 14 | 11 | 15 | 10 |
|
| 18 | 14 | 16 | 12 |
|
| - * | - | - | - |
|
| - | - | - | - |
|
| - | - | - | 12 |
|
| 28 | 25 | 27 | 27 |
|
| 21 | 20 | 21 | 23 |
|
| 24 | 23 | 25 | 26 |
|
| 14 | 17 | 12 | 17 |
|
| - | - | 10 | 10 |
|
| 10 | 12 | 11 | 11 |
|
| 50 | 41 | 42 | 39 |
|
| 32 | 30 | 31 | 38 |
|
| 34 | 33 | 35 | 37 |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| 22 | 20 | 21 | 25 |
|
| 17 | 18 | 17 | 19 |
|
| 21 | 19 | 21 | 22 |
|
| 29 | 27 | 22 | 20 |
|
| 18 | 18 | 19 | 18 |
|
| 21 | 22 | 21 | 19 |
| DMSO | - | 10 | - | - |
| Amoxicillin | 30 | 30 | 30 | 30 |
*(-) indicates no activity.
Minimum inhibition concentration (MIC) mg/ mL of synthetic compounds 1–27.
| Comp. | Minimum Inhibition Concentration (MIC) mg/mL | |||
|---|---|---|---|---|
|
|
|
|
| |
|
| 125 | 250 | 250 | 250 |
|
| 500 | - | - | - |
|
| 500 | - | 250 | - |
|
| - * | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| 100 | 250 | 150 | 125 |
|
| 125 | 125 | 125 | 100 |
|
| 120 | 150 | 100 | 100 |
|
| - | 500 | 500 | 250 |
|
| - | - | - | 500 |
|
| 500 | 500 | 500 | - |
|
| 31 | 50 | 63 | 100 |
|
| 125 | 200 | 125 | 125 |
|
| 50 | 50 | 31 | 50 |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| 100 | 110 | 120 | 115 |
|
| 90 | 90 | 100 | 95 |
|
| 95 | 100 | 110 | 100 |
|
| 150 | 120 | 125 | 118 |
|
| 125 | 110 | 92 | 100 |
|
| 130 | 110 | 100 | 105 |
*(-) indicates no activity.